Use of platelet-rich plasma for COVID-19-related olfactory loss: a randomized controlled trial.

Carol H YanSophie S JangHung-Fu C LinYifei MaAshoke R Khanwalkar Anthony Thai Zara M Patel

Published in: International forum of allergy & rhinology (2022)

Olfactory function following COVID-19 can improve spontaneously after 6 months and can improve to a greater extent with PRP injection. These data build on the promise of PRP to be a safe potential treatment option for patients with COVID-19-related smell loss, and larger-powered studies will help further assess its efficacy.

Keyphrases

platelet rich plasma
coronavirus disease
sars cov
big data
risk assessment
machine learning
respiratory syndrome coronavirus
deep learning
drug induced
data analysis